Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radionuclides in endocrine imaging

M P Sandler1, D Delbeke

  • 1Department of Radiology and Radiological Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee.

Radiologic Clinics of North America
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[FDG-PET/CT in oncology. German Guideline].

Nuklearmedizin. Nuclear medicine·2007
Same author

Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.

European journal of nuclear medicine and molecular imaging·2004
Same author

Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography.

Clinical nuclear medicine·2001
Same author

Positron emission tomography imaging in oncology.

Radiologic clinics of North America·2001
Same author

F-18 FDG uptake in a bone infarct: a case report.

Clinical nuclear medicine·2001
Same author

Orbito-frontal epilepsy masquerading as temporal lobe epilepsy-a case report.

Seizure·2001
Same journal

Orbital Imaging.

Radiologic clinics of North America·2026
Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026
Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026
Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026
Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026
Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026
See all related articles

This review covers radiopharmaceuticals for endocrine imaging, detailing radionuclide characteristics and clinical applications for diagnosing endocrine gland disorders. It highlights the use of Octreoscan 111 for neuropeptide imaging.

Area of Science:

  • Nuclear medicine
  • Endocrinology
  • Radiopharmaceutical science

Background:

  • Endocrine imaging relies on radiopharmaceuticals to diagnose diseases.
  • Standard and novel techniques are employed for scintigraphic endocrine imaging.

Purpose of the Study:

  • To review radiopharmaceuticals for endocrine imaging.
  • To discuss radionuclide characteristics and clinical applications.
  • To introduce neuropeptide imaging agents like Octreoscan 111.

Main Methods:

  • Literature review of radiopharmaceuticals in endocrine imaging.
  • Discussion of radionuclide properties for scintigraphy.
  • Overview of clinical applications in endocrine disorders.

Main Results:

Related Experiment Videos

  • Radiopharmaceuticals are crucial for diagnosing endocrine system diseases.
  • Specific radionuclide/radiopharmaceutical characteristics are essential for successful imaging.
  • Various scintigraphic agents aid in diagnosing disorders of endocrine glands.

Conclusions:

  • Radiopharmaceuticals are vital tools in endocrine diagnostics.
  • Understanding agent characteristics improves imaging success.
  • Emerging agents like Octreoscan 111 offer new diagnostic possibilities.